CAJ | 학술논문

目的探讨胸痹1号合剂治疗冠心病心绞痛的临床疗效.方法将90例冠心病心绞痛患者随机分为治疗组60例和对照组30例.对照组予常规西药治疗,治疗组在对照组基础上加服胸痹1号合剂.观察两组治疗后心脏病发作次数、持续时间和程度、临床症状缓解情况及心电图变化情况.结果治疗组症状总有效率、心电图总有效率分别为95.0％、90.0％,均优于对照组的76.7％、73.3％(x2=9.7、7.8,均P＜0.05).结论胸痹1号合剂能有效改善冠脉供血,减轻心肌缺血,缓解冠心病心绞痛胸闷、胸痛等症状,对冠心病心绞痛治疗安全、有效,值得临床推广应用
목적 탐토흉비1호합제치료관심병심교통적림상료효.방법 장90례관심병심교통환자수궤분위치료조60례화대조조30례.대조조여상규서약치료,치료조재대조조기출상가복흉비1호합제.관찰량조치료후심장병발작차수、지속시간화정도、림상증상완해정황급심전도변화정황.결과 치료조증상총유효솔、심전도총유효솔분별위95.0％、90.0％,균우우대조조적76.7％、73.3％(x2=9.7、7.8,균P＜0.05).결론 흉비1호합제능유효개선관맥공혈,감경심기결혈,완해관심병심교통흉민、흉통등증상,대관심병심교통치료안전、유효,치득림상추엄응용
Objective To explore the effect of Xiongbiyihao mixture in the treatment of coronary heart disease with angina pectoris.Methods 90 coronary heart disease patients with angina pectoris were divided into the treatment group( 60 cases) and control group( 30 cases).The control group was given routine westerm medicine therapy,and the treatment group was administered with Xiongbiyihao mixture at the base of the control group.Ater treatment,the heart disease attack frequency,duration,and degree,clinical symptoms and electrocardiogram changes of the two groups were observed.Results The total efficiency symptoms of and electrocardiogram of the treatment group was 95.0％,90.0％,respectively,and was higher than that of the control group(76.7％,73.3％ ) ( x2 =9.7,x2 =7.8,all P ＜ 0.05).Conclusion Xiongbiyihao mixture could effectively improve the coronary blood,reduce myocardial ischemia,and alleviate the symptoms of angina pectoris,chest tightness,chest pain.It is safe and effective in the treatment of angina pectoris,and worthy of clinical application.